Radiofrequency Ablation of Liver Metastases from Colorectal Cancer: a Literature Review

Overview

Journal Gut Liver

Specialty Gastroenterology

Date 2013 Feb 21

PMID 23422905

Citations 30

Authors

Yasunori Minami

Masatoshi Kudo

Affiliations

Soon will be listed here.

Abstract

Liver metastases occur in up to 60% of patients with colorectal cancer, and the control of liver metastases is considered to be of primary importance because it is a critical factor in determining prognosis. Radiofrequency ablation (RFA) therapy is one of the least invasive techniques for unresectable hepatic malignancies and can be performed safely using percutaneous, laparoscopic, or open surgical techniques. The local tumor progression rates after RFA for colorectal liver metastases range from 8.8% to 40.0%, and 5-year survival rates range from 20.0% to 48.5%. No prospective, randomized trials comparing the efficacy of RFA with that of surgical resection for colorectal liver metastases are currently available. However, some retrospective studies have reported that patients who received RFA had a survival rate similar to that observed in surgically treated groups, while other studies have reported better survival among patients who underwent surgical resection. The use of a laparoscopic or open surgical approach allows the repeated placement of RFA electrodes at multiple sites to ablate larger tumors. An accurate evaluation of treatment response is very important for the success of RFA therapy because a sufficient safety margin (at least 0.5 cm) can prevent local tumor progression. This review critically summarizes the current status of RFA for liver metastases from colorectal cancer.

Citing Articles

Fiber Bragg Grating Thermometry and Post-Treatment Ablation Size Analysis of Radiofrequency Thermal Ablation on Ex Vivo Liver, Kidney and Lung.

Korganbayev S, Bianchi L, Girgi C, Vergantino E, Santucci D, Faiella E Sensors (Basel). 2025; 25(1.

PMID: 39797036 PMC: 11723473. DOI: 10.3390/s25010245.

Improving the prediction of patient survival with the aid of residual convolutional neural network (ResNet) in colorectal cancer with unresectable liver metastases treated with bevacizumab-based chemotherapy.

Chiu S, Li H, Chang W, Wu C, Lin H, Lo C Cancer Imaging. 2024; 24(1):165.

PMID: 39696483 PMC: 11654025. DOI: 10.1186/s40644-024-00809-1.

A Case of Adrenocortical Carcinoma With a Favorable Tumor Control by Radiofrequency Ablation for Liver Metastasis.

Kitsugi K, Kawata K, Kakizawa K, Noritake H J Investig Med High Impact Case Rep. 2023; 11:23247096231218135.

PMID: 38105189 PMC: 10729623. DOI: 10.1177/23247096231218135.

Ablative Therapy in Non-HCC Liver Malignancy.

Robinson T, Pebror T, Krosin M, Koniaris L Cancers (Basel). 2023; 15(4).

PMID: 36831543 PMC: 9954041. DOI: 10.3390/cancers15041200.

Image Fusion Involving Real-Time Transabdominal or Endoscopic Ultrasound for Gastrointestinal Malignancies: Review of Current and Future Applications.

Singh B, Cazacu I, Deza C, Rigaud B, Saftoiu A, Gruionu G Diagnostics (Basel). 2022; 12(12).

PMID: 36553225 PMC: 9777678. DOI: 10.3390/diagnostics12123218.

References

Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K . Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol. 2011; 21(11):2336-43. DOI: 10.1007/s00330-011-2197-0. View

Konopke R, Kersting S, Bergert H, Bloomenthal A, Gastmeier J, Saeger H . Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis. 2006; 22(2):201-7. DOI: 10.1007/s00384-006-0134-5. View

Berber E, Siperstein A . Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol. 2008; 15(10):2757-64. DOI: 10.1245/s10434-008-0043-7. View

Bartolozzi C, Lencioni R . Ethanol injection for the treatment of hepatic tumours. Eur Radiol. 1996; 6(5):682-96. DOI: 10.1007/BF00187673. View

Topal B, Aerts R, Penninckx F . Laparoscopic radiofrequency ablation of unresectable liver malignancies: feasibility and clinical outcome. Surg Laparosc Endosc Percutan Tech. 2003; 13(1):11-5. DOI: 10.1097/00129689-200302000-00003. View

Yu J, Rofsky N . Hepatic metastases: perilesional enhancement on dynamic MRI. AJR Am J Roentgenol. 2006; 186(4):1051-8. DOI: 10.2214/AJR.04.1698. View

Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y . Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg. 2009; 25(6):445-60. DOI: 10.1159/000184736. View

Lee W, Yun S, Chun H, Lee W, Kim S, Choi S . Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol. 2008; 42(8):945-9. DOI: 10.1097/MCG.0b013e318064e752. View

Kudo M . Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol. 2004; 39(3):205-14. DOI: 10.1007/s00535-003-1280-y. View

10.

Omata M, Lesmana L, Tateishi R, Chen P, Lin S, Yoshida H . Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010; 4(2):439-74. PMC: 2900561. DOI: 10.1007/s12072-010-9165-7. View

11.

Machi J, Oishi A, Mossing A, Furumoto N, Oishi R . Hand-assisted laparoscopic ultrasound-guided radiofrequency thermal ablation of liver tumors: a technical report. Surg Laparosc Endosc Percutan Tech. 2002; 12(3):160-4. DOI: 10.1097/00129689-200206000-00004. View

12.

Liu S, Lee K, Bo-San Lai P . Needle track seeding: a real hazard after percutaneous radiofrequency ablation for colorectal liver metastasis. World J Gastroenterol. 2009; 15(13):1653-5. PMC: 2669953. DOI: 10.3748/wjg.15.1653. View

13.

Khan A, Morris-Stiff G, Makuuchi M . Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg. 2008; 16(2):137-44. DOI: 10.1007/s00534-008-0016-z. View

14.

Ni Y, Chen F, Mulier S, Sun X, Yu J, Landuyt W . Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent. Eur Radiol. 2006; 16(5):1031-40. DOI: 10.1007/s00330-005-0094-0. View

15.

Abitabile P, Hartl U, Lange J, Maurer C . Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol. 2006; 33(1):67-71. DOI: 10.1016/j.ejso.2006.10.040. View

16.

Knudsen A, Kannerup A, Mortensen F, Nielsen D . Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy. Acta Radiol. 2009; 50(7):716-21. DOI: 10.1080/02841850902991634. View

17.

Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G . Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002; 89(10):1206-22. DOI: 10.1046/j.1365-2168.2002.02168.x. View

18.

Dietrich C, Ignee A, Trojan J, Fellbaum C, Schuessler G . Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut. 2004; 53(3):401-5. PMC: 1773968. DOI: 10.1136/gut.2003.026260. View

19.

Berber E, Tsinberg M, Tellioglu G, Simpfendorfer C, Siperstein A . Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg. 2008; 12(11):1967-72. DOI: 10.1007/s11605-008-0622-8. View

20.

Gillams A, Lees W . Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009; 19(5):1206-13. DOI: 10.1007/s00330-008-1258-5. View